Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Digestive Diseases and Sciences

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1018876400528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation and identification of human faecal anaerobic bacteria producing β-galactosidase (a new methodology)

  1996influential reference
• Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

  1995cited by this paper
• Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease

  1995cited by this paper
• Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults.

  1994cited by this paper
• Molecular evidence for two forms of Crohn disease.

  1994cited by this paper
• Lactulose--a potential drug for the treatment of inflammatory bowel disease.

  1994cited by this paper
• Regulatory effects of bifidobacteria on the growth of other colonic bacteria.

  1994cited by this paper
• [Decrease of fecal beta-galactosidase activity in Crohn disease].

  1993cited by this paper
• Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.

  1992cited by this paper
• The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

  1991influential reference
• An elective and selective isolation medium for Bifidobacterium spp.

  1990influential reference
• Influence of mucin on glycosidase, protease and arylamidase activities of human gut bacteria grown in a 3-stage continuous culture system.

  1989cited by this paper
• Total parenteral nutrition and the function of the intestinal microflora in Crohn's disease.

  1988cited by this paper
• The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.

  1988cited by this paper
• Increased faecal glycosidases in patients with Crohn's disease.

  1987cited by this paper
• The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.

  1984cited by this paper
• Anaerobic gram-negative faecal flora in patients with Crohn's Disease and healthy subjects

  1983cited by this paper
• Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease.

  1983cited by this paper
• The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease.

  1981cited by this paper
• The faecal flora of patients with Crohn's disease

  1981cited by this paper
• New medium for selection and presumptive identification of the Bacteroides fragilis group

  1978influential reference
• Influence of inflammatory bowel disease on intestinal microflora.

  1978cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper
• Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease

  1974cited by this paper
• Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.

  1967cited by this paper

• Microencapsulation of the probiotic Bifidobacterium longum by spray-drying: Formulation and process optimisation

  2026cites this paper
• Research progress on the use of polyphenols in the treatment of Crohn’s disease

  2025cites this paper
• A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism

  2024cites this paper
• An indicator of Crohn’s disease severity based on Turing patterns

  2023cites this paper
• Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease

  2022cites this paper
• Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin

  2022cites this paper
• Probiotics: Origin, Products, and Regulations in India

  2021cites this paper
• Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease

  2021cites this paper
• Encapsulation of Lactobacillus reuteri in W1/O/W2 double emulsions: Formulation, storage and in vitro gastro-intestinal digestion stability

  2021cites this paper
• Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease

  2021cites this paper
• Biochemical and molecular characterization of lactase producing bacterium isolated from dairy effluent

  2020cites this paper
• Bifidobacterium breve UCC2003 Induces a Distinct Global Transcriptomic Program in Neonatal Murine Intestinal Epithelial Cells

  2020cites this paper
• Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health

  2020cites this paper
• Connection between the Gut Microbiome, Systemic Inflammation, Gut Permeability and FOXP3 Expression in Patients with Primary Sjögren’s Syndrome

  2020cites this paper
• Lactose intolerance in patients with inflammatory bowel diseases and dietary management in prevention of osteoporosis.

  2020cites this paper
• Bifidobacterium breve UCC2003 induces a distinct global transcriptomic programme in neonatal murine intestinal epithelial cells

  2020cites this paper
• The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.

  2019cites this paper
• Metabolic networks of the human gut microbiota.

  2019cites this paper
• Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

  2019cites this paper
• Advanced colon-specific delivery systems for treating local disorders

  2019cites this paper
• Analysis of gut microbiota revealed Lactococcus garviaeae could be an indicative of skin ulceration syndrome in farmed sea cucumber Apostichopus japonicus

  2018cites this paper
• Probiotics in IBD: Combining in vitro and in vivo models for selecting strains with both anti-inflammatory potential as well as a capacity to restore the gut epithelial barrier

  2018cites this paper
• Isolation, Cultivation, and Storage of Bifidobacteria

  2018cites this paper
• Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats.

  2017cites this paper
• Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity

  2017cites this paper
• Multistrain Probiotics: The Present Forward the Future

  2016cites this paper
• Chapter 21 – The Role of the Microbiota and Potential for Dietary Intervention in Chronic Fatigue Syndrome

  2016cites this paper
• Probiotics and its Effects on Human Health-A Review

  2016cites this paper
• Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease

  2016cites this paper
• Mucosa-attached bacterial community in Crohn's disease coheres with the clinical disease activity index.

  2016cites this paper
• An overview of the bacterial contribution to Crohn disease pathogenesis.

  2016cites this paper
• Effect of Overgrowth or Decrease in Gut Microbiota on Health and Disease

  2016cites this paper
• Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis

  2015cites this paper
• Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages

  2015cites this paper
• La libération modifiée de principes actifs, développement de deux approches

  2015cites this paper
• Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance.

  2015cites this paper
• Inulin and Health Benefits

  2014cites this paper
• A global investigation of gene deletion strains that affect premature stop codon bypass in yeast, Saccharomyces cerevisiae.

  2014cites this paper
• Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders.

  2014cites this paper
• Kapitel 3 – Erkrankungen der Gastrointestinalorgane∗

  2014cites this paper
• Genome-wide association and sequencing studies on colorectal cancer.

  2013cites this paper
• Anti-Inflammatory Properties of Genetically Modified Lactic Acid Bacteria

  2013cites this paper
• Probiotics and Prebiotics in Crohn’s Disease

  2013cites this paper
• Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice.

  2012cites this paper
• Evaluation of the utility of probiotics for the prevention of infections in a model of the skin

  2012cites this paper
• Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for “Gibsons' Conundrum”

  2012cites this paper
• Clinical utility of probiotics in inflammatory bowel disease.

  2011cites this paper
• Expanding Applications: The Potential Usage of 5-Aminosalicylic Acid in Diverticular Disease

  2011cites this paper
• Health benefits of probiotics: are mixtures more effective than single strains?

  2011cites this paper
• 4 – Indigenous Flora

  2011cites this paper
• Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases

  2011cites this paper
• The Role of Dysbiosis in Inflammatory Bowel Diseases

  2011cites this paper
• Probiotics and Inflammatory Immune Responses

  2010cites this paper
• Dietary components and immune function

  2010cites this paper
• Facteurs de virulence de Escherichia coli adhérents et invasifs associés à la maladie de Crohn : caractérisation et régulation de leur expression

  2010cites this paper
• Enzymatically degraded Eurylon 6 HP‐PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients

  2010cites this paper
• The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease

  2010cites this paper
• Lactobacillus plantarum Prevents the Upregulation of Adhesion Molecule Expression in an Experimental Colitis Model

  2010cites this paper
• The application of probiotic fermented milks in cancer and intestinal inflammation

  2010cites this paper
• Impact of Administered Bifidobacterium on Murine Host Fatty Acid Composition

  2010cites this paper
• Isolement, identification et caractérisation de souches à activité probiotique depuis les fèces de bébés alimentés exclusivement de lait maternel

  2010cites this paper
• The role of the gut microbiota in inflammatory diseases of childhood

  2010cites this paper
• Enzymatically activated coated multiparticulates containing theophylline for colon targeting

  2010cites this paper
• Chapter 10 – Prebiotics in the Gastrointestinal Tract

  2010cites this paper
• CHAPTER 45 – Inflammatory Bowel Disease

  2009cites this paper
• Functional Disaccharides Lactulose, Lactitol, and Lactose

  2009cites this paper
• Novel polymeric film coatings for colon targeting: Drug release from coated pellets.

  2009cites this paper
• INULIN - POTENCIJALNI PREBIOTIK INULIN-POTENTIAL PREEIOTIC

  2009cites this paper
• [Inulin--potential prebiotic].

  2009cites this paper
• Capítulo 104 – Prescripción de probióticos

  2009cites this paper
• Characterization of ethylcellulose: starch-based film coatings for colon targeting

  2009cites this paper
• Review article: the current and evolving treatment of colonic diverticular disease

  2009cites this paper
• Microbiological Theory of Autism in Childhood

  2009cites this paper
• Galacto-oligosaccharides and Other Products Derived from Lactose

  2009cites this paper
• Colon targeting with bacteria-sensitive films adapted to the disease state.

  2009cites this paper
• Probiotics in Clinical Practice: An Overview

  2008cites this paper
• Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.

  2008cites this paper
• Drugs from hidden bugs: their discovery via untapped resources.

  2008cites this paper
• The Effect of Mineral-induced Alkaline Reduced Water on the DSS-induced Acute Inflammatory Bowel Disease Mouse Model

  2008cites this paper
• Polymère insoluble dans l'eau : revêtements de film à base de dérivés d'amidon modifié pour cibler le colon

  2008cites this paper
• Folienbeschichtungen aus wasserunlöslichem Polymer und modifiziertem Stärkederivat zur Dickdarmansteuerung

  2008cites this paper
• Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease.

  2007cites this paper
• Bioecological control of inflammatory bowel disease.

  2007cites this paper
• Probiotiques et régulation de la réponse immune allergique et inflammatoire

  2007cites this paper
• Review article: probiotics in gastrointestinal and liver diseases

  2007cites this paper
• Current views on the use of probiotics in begnign diseases of the large intestine

  2007cites this paper
• Molecular characterisation of the gut microflora of healthy and inflammatory bowel disease cats using fluorescence in situ hybridisation with special reference to Desulfovibrio spp.

  2007cites this paper
• Is Crohn’s disease due to defective immunity?

  2006cites this paper
• The Family Bifidobacteriaceae

  2006cites this paper
• Probiotics as flourishing benefactors for the human body.

  2006cites this paper
• Evolving knowledge and therapy of inflammatory bowel disease

  2006cites this paper
• Lactose intolerance: the role of colonic metabolism

  2006cites this paper
• A method for describing and evaluating naturopathic whole practice.

  2006cites this paper
• Characterization of human intestinal bifidobacteria using competitive PCR and PCR-TTGE.

  2006cites this paper
• Modifying the Human Intestinal Microbiota with Prebiotics

  2006cites this paper
• Probiotics: their role in the treatment and prevention of disease

  2006cites this paper
• Lactic acid bacteria: microbiological and functional aspects

  2006cites this paper
• Genetic and molecular determinants in inflammatory bowel disease

  2006cites this paper
• Chapter 22 – Pre-, Pro-, and Synbiotics in Clinical Enteral Nutrition

  2005cites this paper
• Use of prebiotics for inflammatory bowel disease.

  2005cites this paper